Adherium Ltd (ADR) - Cash Flow Conversion Efficiency

Latest as of December 2025: 9.437x

Based on the latest financial reports, Adherium Ltd (ADR) has a cash flow conversion efficiency ratio of 9.437x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-7.43 Million ≈ $-5.26 Million USD) by net assets (AU$-787.24K ≈ $-557.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Adherium Ltd (ADR) market capitalisation for the company's overall valuation and market capitalisation.

Adherium Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Adherium Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Adherium Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Adherium Ltd ranked by their cash flow conversion efficiency. Explore Adherium Ltd (ADR) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
STS Global Income & Growth Trust PLC
LSE:STS
0.011x
Albright Metals Ltd
AU:ABR
-0.128x
MacKenzie Realty Capital, Inc. Common Stock
NASDAQ:MKZR
0.010x
OCEAN-GEOLOOP AS NK -01
F:FQ4
N/A
Boqii Holding Limited
NYSE MKT:BQ
0.018x
iTonic Holdings Ltd.
NASDAQ:ITOC
-0.050x
MS INTERNATIONAL plc
LSE:MSI
-0.025x
Chakana Copper Corp
V:PERU
-0.248x

Annual Cash Flow Conversion Efficiency for Adherium Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Adherium Ltd from 2013 to 2025. View Adherium Ltd stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-4.76 Million
≈ $-3.37 Million
AU$-9.98 Million
≈ $-7.06 Million
2.096x +227.98%
2024-06-30 AU$6.48 Million
≈ $4.59 Million
AU$-10.61 Million
≈ $-7.51 Million
-1.638x -62.64%
2023-06-30 AU$9.21 Million
≈ $6.52 Million
AU$-9.28 Million
≈ $-6.56 Million
-1.007x +41.98%
2022-06-30 AU$5.54 Million
≈ $3.92 Million
AU$-9.61 Million
≈ $-6.80 Million
-1.736x -116.08%
2021-06-30 AU$14.04 Million
≈ $9.93 Million
AU$-11.27 Million
≈ $-7.98 Million
-0.803x +62.85%
2020-06-30 AU$3.38 Million
≈ $2.39 Million
AU$-7.32 Million
≈ $-5.18 Million
-2.162x +84.80%
2019-06-30 AU$830.00K
≈ $587.28K
AU$-11.81 Million
≈ $-8.35 Million
-14.225x -1754.91%
2018-06-30 AU$12.81 Million
≈ $9.06 Million
AU$-9.82 Million
≈ $-6.95 Million
-0.767x -50.35%
2017-06-30 AU$22.70 Million
≈ $16.07 Million
AU$-11.58 Million
≈ $-8.19 Million
-0.510x -76.99%
2016-06-30 AU$27.46 Million
≈ $19.43 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.288x -43364.50%
2015-06-30 AU$34.53 Million
≈ $24.43 Million
AU$23.00K
≈ $16.27K
0.001x +100.07%
2014-06-30 AU$2.17 Million
≈ $1.53 Million
AU$-2.16 Million
≈ $-1.53 Million
-0.998x +0.00%
2014-03-31 AU$2.31 Million
≈ $1.64 Million
AU$-2.31 Million
≈ $-1.63 Million
-0.998x -24548.25%
2013-06-30 AU$3.50 Million
≈ $2.48 Million
AU$-14.19K
≈ $-10.04K
-0.004x --

About Adherium Ltd

AU:ADR Australia Medical Devices
Market Cap
$3.11 Million
AU$4.39 Million AUD
Market Cap Rank
#29506 Global
#1666 in Australia
Share Price
AU$0.08
Change (1 day)
-2.44%
52-Week Range
AU$0.00 - AU$0.20
All Time High
AU$10.31
About

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more